Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by Camphikefishon Feb 19, 2022 6:07pm

449 Views

Post# 34445468

Partnership

It is interesting to me with the latest CR numbers produced by IB their stock has gone from 40 to 7 or so in the last 12 months . Seems as if the stock would've realized an enormous boost recently . Someone mentioned bcg is in short supply which is part of the 1-2 punch they offer . Why not marry up tld-1433 to the mix and partner up ? Just throwing it out there and do not wish to ruffle any feathers . Thoughts ?

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market